Insta
Covid-19 vaccine - representative image (Twitter)
In a major step towards India and Russia's joint effort to fight the COVID-19 pandemic, the clinical trials of Russian vaccine Sputnik V will begin in India this month, reports Times of India.
Making the announcement, the chief executive of Russian Direct Investment Fund (RDIF) Kirill Dmitriev said that the clinical trials of Sputnik V vaccine will also begin in the Kingdom of Saudi Arabia (KSA), United Arab Emirates (UAE), Philippines and Brazil.
This comes even as Russia on 26 August had already launched a mass post-registration study of the vaccine involving more than 40,000 people, just days before AstraZeneca had started the phase-3 trial of its vaccine candidate in the United States (US) with 30,000 participants.
Russia registered Sputnik V as the world's first vaccine against COVID-19 on 11 August. The candidate has been developed jointly by the RDIF and the Gamaleya National Research Center of Epidemiology and Microbiology.
It should be noted that RDIF in an earlier stated that the phase-1 and phase-2 trial results of Sputnik-V showed no serious adverse events for any of the criteria, while such incidences among other vaccine candidates ranged between one per cent to 25 per cent.
RDIF had said that the vaccine successfully generated a stable humoral and cellular immune response in cent per cent of the participants.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest